Drugs / Sodium Iodide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT06100952 | Nov 2023 → Feb 2026 | keratoconus | Epion Therapeutics | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00638092 | Mar 2010 → Apr 2015 | thyroid gland disorder | University of Oxford | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium iodide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00638092 ↗ |